These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8553031)

  • 21. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature.
    Brasington RD; Thorpe-Swenson AJ
    Arthritis Rheum; 1991 May; 34(5):631-3. PubMed ID: 2025315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide).
    Majersik JJ; Caravati EM; Steffens JD
    Clin Toxicol (Phila); 2007; 45(3):270-6. PubMed ID: 17453879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Poisoning caused by a paint stripping agents containing dichloromethane].
    Logemann E; van der Smissen G
    Arch Kriminol; 1991; 188(5-6):159-66. PubMed ID: 1799294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors.
    Calvani N; Silvestris F; Dammacco F
    Ann Ital Med Int; 2001; 16(3):175-8. PubMed ID: 11692907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Scleroderma-like syndrome with bullous morphea during treatment with 5-hydroxytryptophan, carbidopa and flunitrazepam].
    Lampert A; Joly P; Thomine E; Ortoli JC; Lauret P
    Ann Dermatol Venereol; 1992; 119(3):209-11. PubMed ID: 1605525
    [No Abstract]   [Full Text] [Related]  

  • 27. Superficial morphea: 20-year follow up in a patient with concomitant psoriasis vulgaris.
    Saleh Z; Arayssi T; Saleh Z; Ghosn S
    J Cutan Pathol; 2009 Oct; 36(10):1105-8. PubMed ID: 19602063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pesticide-induced scleroderma and early intensive immunosuppressive treatment.
    Sozeri B; Gulez N; Aksu G; Kutukculer N; Akalın T; Kandiloglu G
    Arch Environ Occup Health; 2012; 67(1):43-7. PubMed ID: 22315935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solvent dermatitis.
    Andersen KE
    Prog Clin Biol Res; 1986; 220():133-8. PubMed ID: 2948192
    [No Abstract]   [Full Text] [Related]  

  • 30. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies.
    Kettaneh A; Al Moufti O; Tiev KP; Chayet C; Tolédano C; Fabre B; Fardet L; Cabane J
    J Rheumatol; 2007 Jan; 34(1):97-103. PubMed ID: 17117485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Symptomatic scleroderma caused by bleomycin].
    Bork K; Korting GW
    Hautarzt; 1983 Jan; 34(1):10-2. PubMed ID: 6188716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central auditory processing effects induced by solvent exposure.
    Fuente A; McPherson B
    Int J Occup Med Environ Health; 2007; 20(3):271-9. PubMed ID: 17932017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myeloproliferative disorders due to the use of gasoline as a solvent: report of three cases].
    Bernardini P; Giannandrea F; Voso MT; Sica S
    Med Lav; 2005; 96(2):119-25. PubMed ID: 16001511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disseminated circumscribed acleroderma associated with diffuse scleroderma of an acrosclerotic type].
    Ryckmanns F; Konz B
    Hautarzt; 1980 Feb; 31(2):86-90. PubMed ID: 7399900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scleroderma secondary to silica exposure--a case report.
    Anandan S; Othman M; Cheong I; Chin GL
    Singapore Med J; 1995 Oct; 36(5):559-61. PubMed ID: 8882549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurologic illness associated with occupational exposure to the solvent 1-bromopropane--New Jersey and Pennsylvania, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(48):1300-2. PubMed ID: 19052528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between occupational risk factors and severity markers of systemic sclerosis.
    Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
    J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.
    Peterson LS; Nelson AM; Su WP; Mason T; O'Fallon WM; Gabriel SE
    J Rheumatol; 1997 Jan; 24(1):73-80. PubMed ID: 9002014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liver function of workers occupationally exposed to mixed organic solvents in a petrochemical industry].
    Fernández-D'Pool J; Oroño-Osorio A
    Invest Clin; 2001 Jun; 42(2):87-106. PubMed ID: 11416982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.